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Abstract
Background
We evaluate the association between Trypanosoma cruzi infection and strongyloidiasis in a
cohort of Latin American (LA) migrants screened for both infections in a non-endemic
setting.
Methodology
Case-control study including LA individuals who were systematically screened for T. cruzi
infection and strongyloidiasis between January 2013 and April 2015. Individuals were
included as cases if they had a positive serological result for Strongyloides stercoralis. Con-
trols were randomly selected from the cohort of individuals screened for T. cruzi infection
that tested negative for S. stercoralis serology. The association between T. cruzi infection
and strongyloidiasis was evaluated by logistic regression models.
Principal findings
During the study period, 361 individuals were screened for both infections. 52 (14.4%) indi-
viduals had a positive serological result for strongyloidiasis (cases) and 104 participants
with negative results were randomly selected as controls. 76 (48.7%) indiviuals had a posi-
tive serological result for T. cruzi. Factors associated with a positive T. cruzi serology were
Bolivian origin (94.7% vs 78.7%; p = 0.003), coming from a rural area (90.8% vs 68.7%; p =
0.001), having lived in an adobe house (88.2% vs 70%; p = 0.006) and a referred contact
with triatomine bugs (86.7% vs 63.3%; p = 0.001). There were more patients with a positive
S. stercoralis serology among those who were infected with T. cruzi (42.1% vs 25%; p =
0.023). Epidemiological variables were not associated with a positive strongyloidiasis serol-
ogy. T. cruzi infection was more frequent among those with strongyloidiasis (61.5% vs
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42.3%; p = 0.023). In multivariate analysis, T. cruzi infection was associated with a two-fold
increase in the odds of strongyloidiasis (OR 2.23; 95% CI 1.07–4.64; p = 0.030).
Conclusions
T. cruzi infection was associated with strongyloidiasis in LA migrants attending a tropical dis-
eases unit even after adjusting for epidemiological variables. These findings should encour-
age physicians in non-endemic settings to implement a systematic screening for both
infections in LA individuals.
Author summary
Trypanosoma cruzi infection and strongyloidiasis are neglected tropical diseases, sharing a
similar epidemiological burden in Latin America and producing life-long infections, lead-
ing to high morbidity and mortality. We conducted a case-control study in a non-endemic
setting to evaluate a possible relationship between both infections. High prevalence of
both diseases was found and importantly, T. cruzi infection was associated with a two-fold
increase in the likelihood of strongyloidiasis even after adjusting for epidemiological vari-
ables. A possible explanation is that these two infections share an epidemiological burden
where they are highly prevalent, but also the fact that both diseases are strongly influenced
by socioeconomical factors such as soil contamination, barefoot walking or poor health-
care systems. Moreover, immune alterations produced by S. stercoralis may predispose to
T. cruzi infection. As long as screening for Chagas disease in asymptomatic Latin Ameri-
can adults living in Europe has shown to be cost-effective and in light of the high preva-
lence of strongyloidiasis found in T. cruzi infected patients, a combined screening should
be considered. The potential strongyloidiasis related complications and the benefits from
ivermectin therapy are additional reasons to introduce systematic screening in susceptible
populations.
Introduction
In recent years, the significant increase in the number of Latin American migrants in Europe
has meant the introduction of parasitic endemic infections, such as Trypanosoma cruzi infec-
tion and strongyloidiasis [1–3]. Both are neglected tropical diseases (NTD), sharing a similar
epidemiological profile in Latin America (LA) and producing life-long infections, usually
silent, leading to high morbidity and mortality [4–6].
Chagas disease is a zoonosis endemic to LA countries [6,7], caused by hemoflagellated pro-
tozoan Trypanosoma cruzi, usually after contact with faeces of blood-sucking triatomines [8].
Congenital, organ transplantation and transfusion-related transmission are other principal
routes of T. cruzi infection, which have been described in non-endemic areas [9]. The acute
infection is followed by an asymptomatic chronic stage during years. After 20–30 years, up to
30–40% of patients will develop the symptomatic chronic phase, with cardiac and/or digestive
involvement [8,10,11]. Chagas disease diagnosis in the chronic phase is based on serological
tests [10,11].
Strongyloidiasis is a highly prevalent (over 30–100 million people worldwide) nematode
infection, with a unique life-cycle where Strongyloides stercoralis females reproduce partheno-
genetically to produce an autoinfective cycle that can lead to life-long and barely symptomatic
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carriage [5,12,13]. Nonetheless, in the context of immunosuppression, it can cause severe
forms with larvae dissemination to extraintestinal organs and high mortality rates [14,15]. The
diagnosis of strongyloidiasis is challenging due to irregular larvae output resulting in low sen-
sitivity of common parasitological methods. Serology is a very sensitive test (88–95%) and it
may be useful in the follow-up, as titers usually decrease after successful treatment [16–18].
In the context of migration and the increasing use of immunosuppressive treatments (ste-
roids, monoclonal antibodies. . .), T. cruzi infection and strongyloidiasis have emerged as an
important public health problem in Europe, North America and other areas hosting Latin
American population [3,19]. Some European countries including Spain, have implemented
national programmes to control transfusional and mother-to-child transmission of T. cruzi
[20,21], and recent recommendations for the screening and management of strongyloidiasis in
non-endemic areas have been published [22]. However, European countries are far from
achieving an adequate control of the morbidity caused by these two silent chronic infections.
Besides, little is known about the association between both infections in LA migrants and
whether this eventual association should prompt a joint screening strategy in tropical diseases
clinics.
The main aim of the present study is to evaluate the association between T. cruzi infection
and strongyloidiasis in a cohort of LA migrants screened for both infections in a non-endemic
setting.
Methods
Study setting and design
This is a retrospective case-control study performed at the Tropical Medicine and Interna-
tional Health Department in Hospital Clı́nic, Barcelona. Hospital Clı́nic is a tertiary teaching
hospital and a national reference centre in Spain for Tropical Imported Diseases. Systematic
screening of T. cruzi infection (among others) is performed among adult individuals who have
lived for more than a year in endemic countries, or who are born from mothers with LA ori-
gin. Similarly, strongyloidiasis testing was incorporated in the systematic screening of these
patients in January 2013. Individuals are commonly sent to our outpatient clinic referred by
friends or relatives, primary healthcare professionals or they come by their own initiative.
Participants
Eligible participants of the study were selected from the cohort of adult individuals screened
for T. cruzi infection and strongyloidiasis between January 2013 and April 2015. Individuals
were included as cases if they had a positive serology for S. stercoralis in the screening blood
test. Individuals who had been diagnosed with strongyloidiasis prior to the study period or
had previously been treated with ivermectin were excluded. Controls were randomly selected
from the cohort of individuals who were screened for T. cruzi infection and tested negative for
S. stercoralis serology. Two controls were randomly selected for each case included in the
study.
Study procedures
Eligible participants were invited to participate in the outpatient clinic, after signing the
informed consent form. Individuals were asked for clinical and epidemiological data, which
was filled in a standardized questionnaire. This contained data on sociodemographic variables,
area of origin, residence in rural areas or potential risks of Chagas disease transmission (con-
tact with T. cruzi vector, history of maternal Chagas disease or blood transfusions). Blood
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samples were taken to perform serological tests for T. cruzi, S. stercoralis and HIV infection.
Routine hematology and biochemistry tests (including liver and renal function) were per-
formed in all cases. Eosinophilia was defined as>500 eosinophils/mm3 or a percentage 5%.
Laboratory diagnosis of T. cruzi infection was established by two serological ELISA tests,
following international recommendations [23]. One was a commercial ELISA with recombi-
nant antigens (BioELISA Chagas, Biokit S.A., Barcelona, Spain), and the other was an in-house
ELISA with whole T. cruzi epimastigotes antigen. Diagnosis of T. cruzi infection was defined
by positivity in the two serological tests.
S. stercoralis serological screening was performed with the commercial test IVD-ELISA
(IVD Research, Carlsbad, CA) which detects IgG antibodies by using somatic antigens from
larvae of the parasite. A cut-off of the sample absorbance/0.2 (i)>1.1 is defined as positive.
Individuals were also asked to provide three stool samples from different days for direct micro-
scopic examination. Agar plate culture was also performed in at least one stool sample (when
available) per individual.
Statistical analysis
Stata version 13.1 (Stata Corporation, College Station, TX, USA) was used for statistical analy-
ses. Categorical variables were described by counts and percentages, whereas continuous vari-
ables were expressed as means and standard deviations (SD) or medians and interquartile
ranges (IQRs). The chi-square Pearson test was used to compare the distribution of categorical
variables. The Mann-Whitney U test or the t-student test were used to compare the distribu-
tion of continuous variables.
To analyze the association between exposure variables and strongyloidiasis, logistic regres-
sion models were built to estimate unadjusted or adjusted odds ratios (ORs) with their 95%
confidence interval (95% CI). Results were considered statistically significant if the two-tailed
p-value was<0.05. The likelihood ratio test was used to obtain p-values.
Ethical considerations
The Ethics Committee of Hospital Clı́nic approved this study. Data collection forms were
completely anonymous. Written informed consent was obtained from participants for collect-
ing clinical and epidemiological data.
Results
Cohort characteristics
During the study period, 392 patients were screened for T. cruzi infection in our center. Of
these patients, 361 (92.1%) were also screened for strongyloidiasis, and were then eligible for
the study (see Fig 1). Overall, 52 (14.4%) patients had a positive S. stercoralis serological result
and were then included as cases and 104 out of 309 participants with negative results were ran-
domly selected as controls by simple randomization.
Table 1 shows the baseline characteristics of the cohort. The median age of the patients was
36 years (IQR 29–43) and 100 (64.1%) were women. The vast majority came from Bolivia (135
patients, 86.5%), and the other patients came from several different LA countries. Mean time
in Spain prior to screening was 8.46 years (SD 3.64). There were 124 (79.5%) patients who
came from rural areas, 123 (78.8%) had lived in an adobe house and 115 (74.7%) referred hav-
ing had contact with triatomine bugs. Most patients were asymptomatic and the most com-
mon complaints were abdominal bloating (19.9%), heartburn (11.5%) and abdominal pain
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(9%). Absolute and relative eosinophilia were present in 30 (19.2%) and 50 patients (32.1%),
respectively.
There were 76 (48.7%) patients with a positive T. cruzi serology. Most were women (52;
68.4%) and the median age was 37 years (IQR 30–43). Among those with a positive S. stercora-
lis serology, there were 34 (65.4%) women and the median age was 38 years (IQR 31–44).
Mean serology titers were 5.3 (IQR 1.9–8.7), and 28 patients (53.8%) had titers greater than
2.50. None were positive for HIV. From the 114 (73.1%) patients who had provided at least
one stool sample for examination, 2 (1.8%) had one positive sample for S. stercoralis and 6
(5.3%) had two positive samples. No other helminths were isolated from stool samples,
although 25 (16%) patients had other microorganisms isolated from stool: 3 Giardia lamblia,
10 Blastocystis hominis and 12 Entamoeba sp.
Evaluation of risk factors for T. cruzi infection and S. stercoralis infection
Table 2 shows the main characteristics of patients regarding to whether they had T. cruzi infec-
tion and/or strongyloidiasis.
Gender was not found to be associated with T. cruzi infection (p = 0.273) nor strongyloidia-
sis (p = 0.813). The proportion of patients aged 35 or older was also similar among T. cruzi
(p = 0.307) and S. stercoralis (p = 0.302) infected and non-infected participants.
Factors associated with a positive T. cruzi serology were Bolivian origin (94.7% vs 78.7%;
p = 0.003), coming from a rural area (90.8% vs 68.7%; p = 0.001), having lived in an adobe
house (88.2% vs 70%; p = 0.006) and a referred contact with triatomine bugs (86.7% vs 63.3%;
Fig 1. [Flowchart] Flowchart of individuals screened for S. stercoralis and finally included in the study.
https://doi.org/10.1371/journal.pntd.0006199.g001
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Mean years (SD) 36.84 (11.84) -
< 35 years 66 42.3%











Years (SD) living in Spain 8.46 (3.64) -
Rural area 124 79.5%
Adobe house 123 78.8%
Triatomine bug contact 115 74.7%
Clinical signs and diagnostic tests
Clinical symptoms
Abdominal pain 14 9%
Heartburn 18 11.5%
Abdominal bloating 31 19.9%
Skin lesions 1 0.6%
Eosinophil count
Mean (SD) 293 (358) -
Eosinophilia > 500 30 19.2%
Eosinophilia  1000 7 4.5%
Relative eosinophil count
Mean % (SD) 4.48 (4.90) -
Relative eosinophiliaa 50 32.1%
S. stercoralis positive stool samples 8 7%
Serologic tests
Positive T. cruzi serology 76 48.7%
S. stercoralis serology titersb
Mean (SD) 5.3 (4.5) -
< 2.50 24 46.1%
 2.50 28 53.8%
a Defined as >5% of total leukocyte count
b Of the 52 positive S. stercoralis cases
https://doi.org/10.1371/journal.pntd.0006199.t001
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p = 0.001). There were more patients with a positive S. stercoralis serology among those who
were infected with T. cruzi (42.1% vs 25%; p = 0.023).
Epidemiological variables, such as Bolivian origin (88.5% vs 85.6%; p = 0.619), coming
from a rural area (80.8% vs 78.8%; p = 0.779), having lived in an adobe house (78.8% in both
groups) and a referred contact with triatomine bugs (76.9% vs 73.5%; p = 0.647) were not asso-
ciated with a positive strongyloidiasis serology.
T. cruzi infection was more frequent among those with strongyloidiasis (61.5% vs 42.3%;
p = 0.023). No differences between both groups were found in clinical symptoms, such as
abdominal pain (13.5% vs 6.7%; p = 0.166), heartburn (15.4% vs 9.6%; p = 0.288), and abdomi-
nal bloating (23.1% vs 18.3%; p = 0.478). Isolation of other microorganisms in stool samples
was also not associated with strongyloidiasis (16.7% vs 25%; p = 0.300).
Association between Chagas disease and strongyloidiasis
After adjusting for sex, age, country of origin and rural area, T. cruzi infection was associated
with a two-fold increase in the odds of strongyloidiasis (OR 2.23; 95% CI 1.07–4.64; p = 0.030)
(Table 3). We decided not to adjust for relative eosinophilia as this factor could cause
Table 2. Baseline characteristics of 156 individuals included in the study, according to results on T. cruzi and strongyloidiasis serology.









Women 52 (68.4%) 48 (60%) 0.273 34 (65.4%) 66 (63.5%) 0.813
Age 35 years 47 (61.8%) 43 (53.7%) 0.307 33 (63.5%) 57 (54.8%) 0.302
Bolivian origina 72 (94.7%) 63 (78.8%) 0.003 46 (88.5%) 89 (85.6%) 0.619
Rural area 69 (90.8%) 55 (68.7%) 0.001 42 (80.8%) 82 (78.8%) 0.779
Adobe house 67 (88.2%) 56 (70%) 0.006 41 (78.8%) 82 (78.8%) 1.0
Triatomine bug contact 65 (86.7%) 50 (63.3%) 0.001 40 (76.9%) 75 (73.5%) 0.647
Absolute eosinophiliab 19 (25%) 11 (13.7%) 0.075 20 (38.5%) 10 (9.62%) < 0.001
Relative eosinophiliac 30 (39.5%) 20 (25%) 0.053 28 (53.8%) 22 (21.1%) < 0.001
Clinical symptoms
Abdominal pain 4 (5.3%) 10 (12.5%) 0.114 7 (13.5%) 7 (6.7%) 0.166
Heartburn 8 (10.5%) 10 (12.5%) 0.700 8 (15.4%) 10 (9.6%) 0.288
Abdominal bloating 13 (17.1%) 18 (22.5%) 0.399 12 (23.1%) 19 (18.3%) 0.478
Positive T.cruzi serology - - - 32 (61.5%) 44 (42.3%) 0.023
Positive S. stercoralis serology 32 (42.1%) 20 (25%) 0.023 - - -
S. stercoralis serology titers > 2.50 19 (59.4%) 9 (45%) 0.312 - - -
a Total = 135
b Defined as >500 eosinophils/mm3
c Defined as >5% of total leukocyte count
https://doi.org/10.1371/journal.pntd.0006199.t002
Table 3. Unadjusted and adjusted odds ratios (OR) of the association between baseline characteristics and strongyloidiasis.
Characteristic Unadjusted OR (95% CI) p value Adjusted OR (95% CI) p value
Male sex 0.92 (0.46–1.85) 0.813 1.02 (0.50–2.10) 0.952
Age35 years 1.43 (0.72–2.84) 0.301 1.38 (0.68–2.79) 0.365
Bolivian origin 1.29 (0.47–3.55) 0.615 1.03 (0.35–3.00) 0.954
Rural area 1.13 (0.49–2.60) 0.778 0.81 (0.33–2.00) 0.653
T. cruzi infection 2.18 (1.10–4.31) 0.023 2.23 (1.07–4.64) 0.030
https://doi.org/10.1371/journal.pntd.0006199.t003
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collinearity with strongyloidiasis. Similarly, triatomine bug contact and living in an adobe
house were also not included, since these variables could cause collinearity with rural area.
Discussion
In this retrospective case-control study, we offer an evaluation of the clinical and epidemiolog-
ical characteristics of LA migrants screened for both T. cruzi infection and strongyloidiasis in a
reference unit for tropical diseases. The most important finding of our study is the association
found between both strongyloidiasis and T. cruzi infection.
Almost all individuals screened were young, with no comorbidities—probably reflecting
the overall epidemiological characteristics of global population migrating for work.
The proportion of T. cruzi infection was found to be high, as in other series of imported dis-
eases centers and known to be altered by a positive selection bias [24,25]. This figure is highly
conditioned by the fact that the majority of patients came from Bolivia, which is known to be a
highly endemic country for Chagas disease [6]. In addition, most of them had lived in rural
areas where the high prevalence of the vector is associated to suitable conditions for transmis-
sion such as the presence of adobe houses. Expectedly, T. cruzi infection was associated with
Bolivian origin, having lived in an adobe house and a referred contact with triatomine bugs.
For initially screened patients, strongyloidiasis prevalence was 14.4%. This prevalence rate
seems accordant to that found in similar migrant populations in non-endemic areas [26,27],
although these studies were mostly conducted in HIV patients. Nonetheless, global prevalence
of strongyloidiasis is generally underestimated and data on Bolivian prevalence of this nema-
tode infection is especially scarce [5,28,29]. Considering the potential negative impact on
patients of this life-long infection [15], this high prevalence should prompt the inclusion of
active screening strategies among susceptible populations from LA [22].
In our study, strongyloidiasis was neither associated to the epidemiological nor to the clini-
cal variables recorded. It could have been expected to find an association between a positive
serology and a rural origin or having lived in an adobe house [30,31]. A possible explanation
for this is that the very high prevalence of these risk factors in the whole cohort (around 80%)
could have masked a possible association, but it seems unlikely to be the only explanation.
We found that strongyloidiasis and T. cruzi infection were associated even after adjusting
for the main epidemiological variables. Few formal studies had previously analysed the possi-
ble association between both infections [32,33]. A possible explanation is that these two infec-
tions share an epidemiological burden where they are highly prevalent, but also the fact that
both diseases are strongly influenced by socioeconomical factors such as soil contamination,
barefoot walking or poor healthcare systems. Moreover, Salvador et al [33] reported a co-infec-
tion rate of 18% in those already diagnosed with T. cruzi infection and, interestingly, co-
infected patients were found to have a higher proportion of positive T. cruzi RT-PCR in
peripheral blood. The authors suggested that strongyloidiasis induction of Th2-immune
response may lead to suppression of Th1-mediated immunity and therefore it may predispose
to T. cruzi infection [33,34].
A recent cost-effectiveness study has shown that screening for Chagas disease in asymptom-
atic Latin American adults living in Europe is a cost-effective strategy [35]. In light of the high
prevalence of strongyloidiasis found in T. cruzi infected patients, and that both diseases are
prevalent and silent among Latin American migrants, a combined screening should be consid-
ered. The potential strongyloidiasis related complications and the benefits from ivermectin
therapy are additional reasons to introduce systematic screening in susceptible populations.
The strengths of this study are that serology was performed systematically on the first visit,
minimizing a possible selection bias, and the fact that screening for both T. cruzi and
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strongyloidiasis was achieved in more than 90% of the patients. However, our study has some
limitations that should be acknowledged. First of all, this is an observational retrospective
study and had a relatively small sample size of patients with strongyloidiasis. Secondly, the
diagnosis of strongyloidiasis relied solely in a positive serologic test. A limitation of serology is
that it may have false-positive results due to cross-reaction with filariae and other helminthes
[36], and that it does not certainly indicate current infection [16]. Though these are important
issues, especially in migrant patients where multiple parasite infections are frequent [37],
IVD-ELISA has shown reliable results in term of accuracy, with high positive and negative pre-
dictive values [38]. Actually, more than half of those diagnosed with strongyloidiasis had serol-
ogy titers above 2.50, which was correlated with the highest positive predictive value in one
study [38]. Moreover, no other helminths were isolated from stool samples and the longtime
living in Spain at screening reduces the possibility of a potential cross-reaction. Lastly, another
limitation of our study is that the clear predominance of Bolivian patients compels us to be
cautious with the generalizability of our findings, and further studies with higher proportions
of LA migrants from other countries would be necessary.
In conclusion, T. cruzi infection was found to be associated to strongyloidiasis in LA
migrants attending a tropical diseases unit. These results suggest that both infections are preva-
lent in these individuals and increase the scarce knowledge about the possible relationship
between these two parasites. Finally, our findings should encourage physicians to implement a
systematic screening program for both infections in LA individuals. Further research is needed
in order to explore this possible association and the underlying mechanisms.
Supporting information








Writing – original draft: Pedro Puerta-Alcalde, Joan Gomez-Junyent, Ana Requena-Mendez,
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